Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation

This study is ongoing, but not recruiting participants.

Study NCT00052884 Information provided by National Cancer Institute (NCI)

First Received: January 24, 2003 Last Updated: May 9, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given